These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 25937529)

  • 1. Patient and physician factors associated with participation in cervical and uterine cancer trials: an NRG/GOG247 study.
    Brooks SE; Carter RL; Plaxe SC; Basen-Engquist KM; Rodriguez M; Kauderer J; Walker JL; Myers TK; Drake JG; Havrilesky LJ; Van Le L; Landrum LM; Brown CL
    Gynecol Oncol; 2015 Jul; 138(1):101-8. PubMed ID: 25937529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic Review and Meta-Analysis of the Magnitude of Structural, Clinical, and Physician and Patient Barriers to Cancer Clinical Trial Participation.
    Unger JM; Vaidya R; Hershman DL; Minasian LM; Fleury ME
    J Natl Cancer Inst; 2019 Mar; 111(3):245-255. PubMed ID: 30856272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discordant attitudes and beliefs about cancer clinical trial participation between physicians, research staff, and cancer patients.
    Hillyer GC; Beauchemin M; Hershman DL; Kelsen M; Brogan FL; Sandoval R; Schmitt KM; Reyes A; Terry MB; Lassman AB; Schwartz GK
    Clin Trials; 2020 Apr; 17(2):184-194. PubMed ID: 32009456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective analysis of the influence of older age on physician and patient decision-making when considering enrollment in breast cancer clinical trials (SWOG S0316).
    Javid SH; Unger JM; Gralow JR; Moinpour CM; Wozniak AJ; Goodwin JW; Lara PN; Williams PA; Hutchins LF; Gotay CC; Albain KS
    Oncologist; 2012; 17(9):1180-90. PubMed ID: 22723506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enrollment of Individuals From Racial and Ethnic Minority Groups in Gynecologic Cancer Precision Oncology Trials.
    Mattei LH; Robb L; Banning K; Polan RM; Cote ML
    Obstet Gynecol; 2022 Oct; 140(4):654-661. PubMed ID: 36075065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Organizational and physician factors associated with patient enrollment in cancer clinical trials.
    Jacobs SR; Weiner BJ; Reeve BB; Weinberger M; Minasian LM; Good MJ
    Clin Trials; 2014 Oct; 11(5):565-75. PubMed ID: 24902923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer prevention trials and primary care physicians: factors associated with recommending trial enrollment.
    Battaglia TA; Ash A; Prout MN; Freund KM
    Cancer Detect Prev; 2006; 30(1):34-7. PubMed ID: 16476525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical trial participation among ethnic/racial minority and majority patients with advanced cancer: what factors most influence enrollment?
    Jimenez R; Zhang B; Joffe S; Nilsson M; Rivera L; Mutchler J; Lathan C; Paulk ME; Prigerson HG
    J Palliat Med; 2013 Mar; 16(3):256-62. PubMed ID: 23384245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enrollment of patients with lung and colorectal cancers onto clinical trials.
    Fouad MN; Lee JY; Catalano PJ; Vogt TM; Zafar SY; West DW; Simon C; Klabunde CN; Kahn KL; Weeks JC; Kiefe CI
    J Oncol Pract; 2013 Mar; 9(2):e40-7. PubMed ID: 23814523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Barriers to therapeutic clinical trials enrollment: differences between African-American and white cancer patients identified at the time of eligibility assessment.
    Penberthy L; Brown R; Wilson-Genderson M; Dahman B; Ginder G; Siminoff LA
    Clin Trials; 2012 Dec; 9(6):788-97. PubMed ID: 23033547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demographic reporting and language exclusion in gynecologic oncology clinical trials.
    Lee SS; Dinicu AI; Arthurs L; Shields D; Pothuri B; Lightfoot MDS
    Am J Obstet Gynecol; 2024 Jan; 230(1):73.e1-73.e14. PubMed ID: 37751830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Addressing clinical trials: can the multidisciplinary Tumor Board improve participation? A study from an academic women's cancer program.
    Kuroki L; Stuckey A; Hirway P; Raker CA; Bandera CA; DiSilvestro PA; Granai CO; Legare RD; Sakr BJ; Dizon DS
    Gynecol Oncol; 2010 Mar; 116(3):295-300. PubMed ID: 20042225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of physician recommendation on enrollment in the Breast Cancer Chemoprevention Trial.
    Kinney AY; Richards C; Vernon SW; Vogel VG
    Prev Med; 1998; 27(5 Pt 1):713-9. PubMed ID: 9808803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment.
    Lara PN; Higdon R; Lim N; Kwan K; Tanaka M; Lau DH; Wun T; Welborn J; Meyers FJ; Christensen S; O'Donnell R; Richman C; Scudder SA; Tuscano J; Gandara DR; Lam KS
    J Clin Oncol; 2001 Mar; 19(6):1728-33. PubMed ID: 11251003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thoracic Radiation Oncology Clinical Trial Accrual and Reasons for Nonenrollment: Results of a Large, Prospective, Multiyear Analysis.
    Mesko S; Ning MS; Lakomy D; Verma V; Chang JY; O'Reilly M; Jeter MD; Gandhi SJ; Lin SH; Nguyen QN; Liao Z; Welsh J; Chen AB; Hahn S; Gomez DR
    Int J Radiat Oncol Biol Phys; 2020 Aug; 107(5):897-908. PubMed ID: 32360653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Patient Comorbid Conditions With Cancer Clinical Trial Participation.
    Unger JM; Hershman DL; Fleury ME; Vaidya R
    JAMA Oncol; 2019 Mar; 5(3):326-333. PubMed ID: 30629092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Most children with cancer are not enrolled on a clinical trial in Canada: a population-based study.
    Pole JD; Barber R; Bergeron RÉ; Carret AS; Dix D; Kulkarni K; Martineau E; Randall A; Stammers D; Strahlendorf C; Strother DR; Truong TH; Sung L
    BMC Cancer; 2017 Jun; 17(1):402. PubMed ID: 28583094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A population-based assessment of specialty physician involvement in cancer clinical trials.
    Klabunde CN; Keating NL; Potosky AL; Ambs A; He Y; Hornbrook MC; Ganz PA
    J Natl Cancer Inst; 2011 Mar; 103(5):384-97. PubMed ID: 21317382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opinions and expectations of women in the treatment of cervical and uterine cancer in Spain.
    Rodríguez MA; Suess A; Cerdá JC; Carretero ME; Danet A
    Womens Health (Lond); 2011 Nov; 7(6):709-18. PubMed ID: 22040211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minority participation in Gynecologic Oncology Group (GOG) Studies.
    Scalici J; Finan MA; Black J; Harmon MD; Nicolson W; Lankes HA; Brady WE; Rocconi RP
    Gynecol Oncol; 2015 Aug; 138(2):441-4. PubMed ID: 26013697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.